CD40 and neoplasm: Importantly, prior intralesional injection of a parental IgG1 anti-CD40 Ab was demonstrated safe when administered intralesionally11; however, it had no demonstrable anti-tumor effects, further supporting the importance of the Fc portion for optimal in vivo activity.